ReMedys Founder, Board Member and Business Development
Dr. Kaloulis holds a PhD in Molecular Embryology from the University of Geneva, Switzerland. He brings to ReMedys more than 17 years experience in biotechnology, pharmaceutical industry and research.
For several years he has been evaluating, negotiating and managing strategic Innovation, preclinical and clinical partnerships and licensing deals, while proposing and implementing new business models, for a global pharmaceutical company. Before that he developed a profound understanding and network in entrepreneurship and product development as the founder and CEO of 2 start- ups and director of nonclinical development in a biotechnology company. He also worked on technology transfer (business development, spin offs and licensing) in top ranked academic institutes. Dr. Kaloulis’ main focus is on building strategic partnerships between patient groups, and public and private entities to select and advance innovative therapies towards the clinic with appropriate funding.